Capstone Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$355K Sell
5,659
-560
-9% -$32.6K 0.01% 1134
2017
Q1
$318K Sell
6,219
-980
-14% -$46.7K 0.01% 1228
2016
Q4
$307K Sell
7,199
-1,590
-18% -$67.6K 0.01% 1292
2016
Q3
$417K Sell
8,789
-140
-2% -$6.99K 0.01% 1090
2016
Q2
$451K Buy
8,929
+230
+3% +$11.6K 0.01% 991
2016
Q1
$421K Sell
8,699
-530
-6% -$20.4K 0.01% 1029
2015
Q4
$363K Sell
9,229
-30
-0.3% -$1.2K 0.01% 1135
2015
Q3
$352K Sell
9,259
-690
-7% -$29.1K 0.01% 1136
2015
Q2
$395K Sell
9,949
-4,840
-33% -$151K 0.01% 1119
2015
Q1
$396K Buy
14,789
+950
+7% +$26.8K 0.01% 1231
2014
Q4
$406K Sell
13,839
-290
-2% -$7.16K 0.01% 1179
2014
Q3
$285K Buy
14,129
+110
+0.8% +$2.12K 0.01% 1390
2014
Q2
$235K Buy
14,019
+1,949
+16% +$27.6K 0.01% 1518
2014
Q1
$180K Sell
12,070
-780
-6% -$12K 0.01% 1676
2013
Q4
$188K Sell
12,850
-15,270
-54% -$246K 0.01% 1784
2013
Q3
$484K Sell
28,120
-1,010
-3% -$15K 0.01% 1326
2013
Q2
$338K Buy
+29,130
New +$334K 0.01% 1492

Other funds holding AMED

Capstone Asset Management's AMED Position: Q2 2017 in Review

Capstone Asset Management reduced its Amedisys (AMED) stake by 9% in Q2 2017, selling an estimated $32.6K and leaving 5,659 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #1134.

Capstone Asset Management first reported a position in AMED in Q2 2013 and has held it in 17 quarters since. The position peaked at $484K in Q3 2013. 169 funds tracked by Wall St. Rank hold AMED as of Q2 2017.

  • Capstone Asset Management held 5,659 shares of Amedisys worth $355K as of Q2 2017.
  • Capstone Asset Management sold 560 Amedisys shares in Q2 2017, an estimated $32.6K.
  • Amedisys made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1134 holding.
  • Capstone Asset Management first reported a position in Amedisys in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Amedisys position peaked at $484K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Amedisys as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.